{"id":113774,"date":"2026-09-14T16:30:21","date_gmt":"2026-09-14T07:30:21","guid":{"rendered":"https:\/\/japanir.jp\/en\/ir\/3455-20260914-03_wp_executive_change\/"},"modified":"2026-09-14T16:30:21","modified_gmt":"2026-09-14T07:30:21","slug":"3455-20260914-03_wp_executive_change","status":"publish","type":"ir_release","link":"https:\/\/japanir.jp\/en\/company\/company-3455\/ir\/3455-20260914-03_wp_executive_change\/","title":{"rendered":"Notice Regarding Bylaw Changes and Director Appointments"},"content":{"rendered":"<p>This investment corporation submitted for the 7th general meeting of investors a plan to change the management structure, including the appointment of one executive officer, one replacement executive officer, and two supervisory officers. Partial bylaw amendments are also to be approved. The meeting is scheduled for October 29, 2026. Technical changes to remuneration calculation rules for the asset management company are also announced concurrently.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3455","jir_company_name":"HealthCare & Medical Investment Corporation","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-09-14","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/3455-20260914-03.pdf","jir_short_summary":"This investment corporation submitted for the 7th general meeting of investors a plan to change the management structure, including the appointment of one executive officer, one replacement executive officer, and two supervisory officers. Partial bylaw amendments are also to be approved. The meeting is scheduled for October 29, 2026. Technical changes to remuneration calculation rules for the asset management company are also announced concurrently.","jir_summary":"### Overview of Bylaw Changes\nThe investment corporation plans to revise bylaws to respond to the establishment of the Asset Management Association, presenting amendments 1\u20135 including updating current clauses, new electronic provision measures, and handling of usufruct assets that are excluded from asset management fees. In particular, revisions to Articles 9\u201321 clarify conditions for officers such as convocation and chairing, and strengthen the structure by setting an upper limit on the number of executive officers.\n\n### Details of Director Appointments and Schedule\nNew candidate for one executive officer, one candidate for replacement executive officer, and two candidates for supervising officers have been submitted. Executive officer candidate is Yuji Fujise; replacement executive officer candidate is Akashi Muramura; supervising officer candidates are Kaori Sato and Nomu Nakano. Term of office will commence on November 1, 2026 in accordance with the current bylaws. The general meeting is scheduled for October 29, 2026.","jir_financial_highlights":"Unknown: Unknown (Unknown)","jir_category":"","jir_hashtags":"#HealthCare & Medical Investment Corporation - Executive Personnel, #BylawChange, #ShareholdersMeeting, #IRNews","jir_key_figures":"Appointment of one executive officer\nAppointment of one replacement executive officer\nAppointment of two supervising officers","jir_meta_title":"\u3010HealthCare & Medical Investment Corporation\u3011Notice of Bylaw Changes and Director Appointments | 2026","jir_meta_description":"HealthCare & Medical Investment Corporation submits appointments of one executive officer, one replacement executive officer, and two supervising officers along with bylaw changes ahead of the 7th shareholders meeting. Meeting date is October 29, 2026. See key points in this IR document.","jir_og_title":"HealthCare & Medical Investment Corporation: Notice of Bylaw Changes and Director Appointments","jir_og_description":"Overview of new appointments for executive officer, replacement executive officer, and supervising officers and bylaw changes ahead of the 7th shareholders meeting. Meeting date is October 29, 2026.","jir_og_image_url":"\/assets\/og\/company-executive_change.jpg","jir_chart_data_collection":"[]","ir_related_company":17572,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"executive_change","footnotes":""},"sector":[],"importance":[],"class_list":["post-113774","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Notice Regarding Bylaw Changes and Director Appointments - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-3455\/ir\/3455-20260914-03_wp_executive_change\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-3455\/ir\/3455-20260914-03_wp_executive_change\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-3455\/ir\/3455-20260914-03_wp_executive_change\/\",\"name\":\"Notice Regarding Bylaw Changes and Director Appointments - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-09-14T07:30:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-3455\/ir\/3455-20260914-03_wp_executive_change\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-3455\/ir\/3455-20260914-03_wp_executive_change\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-3455\/ir\/3455-20260914-03_wp_executive_change\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Notice Regarding Bylaw Changes and Director Appointments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Notice Regarding Bylaw Changes and Director Appointments - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-3455\/ir\/3455-20260914-03_wp_executive_change\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-3455\/ir\/3455-20260914-03_wp_executive_change\/","url":"https:\/\/japanir.jp\/en\/company\/company-3455\/ir\/3455-20260914-03_wp_executive_change\/","name":"Notice Regarding Bylaw Changes and Director Appointments - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-09-14T07:30:21+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-3455\/ir\/3455-20260914-03_wp_executive_change\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-3455\/ir\/3455-20260914-03_wp_executive_change\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-3455\/ir\/3455-20260914-03_wp_executive_change\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"Notice Regarding Bylaw Changes and Director Appointments"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"related_company_data":{"id":"17572","title":"HEALTHCARE &#038; MEDICAL INV CORP","ticker":"3455"},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/113774","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/ir_release"}],"replies":[{"embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/comments?post=113774"}],"version-history":[{"count":0,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/113774\/revisions"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=113774"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=113774"},{"taxonomy":"importance","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/importance?post=113774"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}